In 185 US veterans with alcohol use disorder, pioglitazone 45 mg did not reduce heavy drinking days in week 14 versus placebo (mean 2.43 vs 2.01; P=0.22), nor secondary drinking or craving measures. It was safe and well tolerated.
RCTn = 185
Dieperink et al. Pioglitazone for the treatment of alcohol use disorder: A randomized controlled trial